Related Experiment Video

Updated: Jul 20, 2026

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
08:49

Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries

Published on: January 22, 2019

Silymarin causes caspases activation and apoptosis in K562 leukemia cells through inactivation of Akt pathway

Xian Zhong1, Yongliang Zhu, Qinghua Lu

  • 1Cancer Institute, Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang Province, China.

Toxicology
|September 5, 2006
PubMed

Insights

Silymarin, a natural antioxidant, effectively inhibits Akt activity and induces apoptosis in leukemia cells. This suggests silymarin shows potential as a novel anti-leukemia therapeutic agent.

Area of Science:

  • Oncology
  • Biochemistry
  • Pharmacology

Background:

  • Cancer, including leukemia, remains a leading cause of mortality worldwide.
  • Akt is frequently overexpressed in malignancies, making it a significant therapeutic target.
  • Silymarin, a flavonoid antioxidant, is clinically used for liver conditions and possesses high safety.

Purpose of the Study:

  • To investigate the anti-leukemia effects of silymarin.
  • To determine silymarin's impact on Akt signaling pathways in leukemia cells.
  • To evaluate silymarin's potential as an anti-leukemia drug candidate.

Main Methods:

  • Treatment of K562 leukemia cells with silymarin.
  • Assay of Akt activity and total Akt levels.
  • Analysis of caspase-9, caspase-3 activation, and PARP cleavage.
  • Assessment of apoptosis and cell growth inhibition.

Main Results:

  • Silymarin significantly inhibited Akt activity without altering total Akt levels.
  • Prominent activation of caspases-9 and -3 was observed.
  • Poly (ADP-ribose) polymerase (PARP) cleavage was evident.
  • Silymarin induced significant apoptotic cell death and growth inhibition in K562 cells.

Conclusions:

  • Silymarin effectively suppresses leukemia cell growth and survival through Akt inhibition and apoptosis induction.
  • Silymarin demonstrates potential as a novel therapeutic agent for leukemia treatment.
  • Further research into silymarin's anti-leukemia mechanisms is warranted.

More Related Videos

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration11:13

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on: June 9, 2023

Related Concept Videos

Caspases01:24

Caspases

Caspase, a family of cysteine proteases, serve as effectors in apoptosis. The ced3 gene in C.elegans was first identified to be involved in apoptosis. This gene encodes the ced-3 caspase that is similar to the interleukin-1-beta converting enzyme or ICE in mammals. In addition to apoptosis, caspases also function in the inflammatory response. Inflammatory caspases are essential in activating pro-inflammatory cytokines that recruit immune cells and block the replication of pathogens inside cells.
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...